Publikacje

Role of adenosine A2A receptors in parkinsonian motor impairment and l-DOPA-induced motor complications. Micaela Morelli, Therese Di Paolo, Jadwiga Wardas, Frederic Calon, Danqing Xiao, Michael A Schwarzschild
Progress in neurobiology,
PMID:17826884
Środa, 21 Listopada 2007
The influence of modifications in imide fragment structure on 5-HT(1A) and 5-HT(7) receptor affinity and in vivo pharmacological properties of some new 1-(m-trifluoromethylphenyl)piperazines. Maria H Paluchowska, Ryszard Bugno, Beata Duszyńska, Ewa Tatarczyńska, Agnieszka Nikiforuk, Tomasz Lenda, Ewa Chojnacka-Wójcik
Bioorganic & medicinal chemistry,
PMID:17825569
Poniedziałek, 1 Października 2007
Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats. Katarzyna Kuter, Maria Smiałowska, Joanna Wierońska, Barbara Zieba, Jadwiga Wardas, Małgorzata Pietraszek, Przemysław Nowak, Izabela Biedka, Wojciech Roczniak, Jolanta Konieczny, Stanisław Wolfarth, Krystyna Ossowska
Brain research,
PMID:17493592
Czwartek, 12 Kwietnia 2007
The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats. J Konieczny, J Wardas, K Kuter, A Pilc, K Ossowska
Neuroscience,
PMID:17224239
Wtorek, 16 Stycznia 2007
Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: implications for Parkinson's disease. K Ossowska, M Smiałowska, K Kuter, J Wierońska, B Zieba, J Wardas, P Nowak, J Dabrowska, A Bortel, I Biedka, G Schulze, H Rommelspacher
Neuroscience,
PMID:16797138
Poniedziałek, 21 Sierpnia 2006
An influence of ligands of metabotropic glutamate receptor subtypes on parkinsonian-like symptoms and the striatopallidal pathway in rats. K Ossowska, J Konieczny, J Wardas, M Pietraszek, K Kuter, S Wolfarth, A Pilc
Amino acids,
PMID:16699817
Poniedziałek, 15 Maja 2006
MTEP, a new selective antagonist of the metabotropic glutamate receptor subtype 5 (mGluR5), produces antiparkinsonian-like effects in rats. K Ossowska, J Konieczny, S Wolfarth, A Pilc
Neuropharmacology,
PMID:15919101
Środa, 7 Grudnia 2005
New therapies for the treatment of Parkinson's disease: adenosine A2A receptor antagonists. Annalisa Pinna, Jadwiga Wardas, Nicola Simola, Micaela Morelli
Life sciences,
PMID:15979104
Poniedziałek, 17 Października 2005
A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long-term paraquat administration in rats: an animal model of preclinical stages of Parkinson's disease? K Ossowska, J Wardas, M Smiałowska, K Kuter, T Lenda, J M Wierońska, B Zieba, P Nowak, J Dabrowska, A Bortel, A Kwieciński, S Wolfarth
The European journal of neuroscience,
PMID:16190885
Czwartek, 29 Września 2005
1,2,3,4-Tetrahydroisoquinoline protects terminals of dopaminergic neurons in the striatum against the malonate-induced neurotoxicity. Elzbieta Lorenc-Koci, Krystyna Gołembiowska, Jadwiga Wardas
Brain research,
PMID:16004976
Poniedziałek, 25 Lipca 2005